首页> 外文期刊>Retina >Travel to high mountain elevations following vitrectomy with intraocular gas
【24h】

Travel to high mountain elevations following vitrectomy with intraocular gas

机译:玻璃体切割手术后用眼内气体前往高山海拔

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the effects and safety of travel by land through high mountainous elevations after surgery in patients who have undergone pars plana vitrectomy with intraocular gas. METHODS: A retrospective cohort study of 75 patients post pars plana vitrectomy with intraocular gas who traveled by land through mountain elevations of up to 3895 feet above sea level within 1 day of surgery. RESULTS: The average rate of ascent through the mountains was 29 ft/min and the maximum theoretical ocular compensation was 0.57 cubic centimeters (cc), which occurred at 4259 feet above sea level. A statistically significant change in postoperative intraocular pressure was found when compared with preoperative (P = 0.010), with two factors influencing this change: the type of gas (C3F8, P = 0.038) and lens status (pseudophakic, P = 0.010), with a mean final intraocular pressure still within the safe range. There were no cases of retinal vascular occlusion, acute elevations of intraocular pressure requiring surgical intervention, or symptomatic visual field loss attributable to elevated intraocular pressure. CONCLUSION: It seems that patients with a complete fill of intraocular gas after pars plana vitrectomy may travel safely by land through mountains with a peak ascent of 3895 feet, final ascent of 2787 feet, and a mean rate of 29 ft/min. These findings can significantly impact patient costs and convenience.
机译:目的:评估手术后经眼睑内窥镜玻璃体切除术的患者在高海拔山区手术后陆路旅行的效果和安全性。方法:一项回顾性队列研究,对75例经眼部平板玻璃体切除术的患者进行了眼内气体手术,他们在手术1天之内陆上穿越了海拔3895英尺的山岭。结果:穿过高山的平均上升速度为29英尺/分钟,最大理论眼补偿为0.57立方厘米(cc),发生在海拔4259英尺处。与术前相比,术后眼压有统计学意义的变化(P = 0.010),有两个因素影响这一变化:气体类型(C3F8,P = 0.038)和晶状体状态(假性眼,P = 0.010),平均最终眼压仍在安全范围内。没有视网膜血管阻塞,需要手术干预的眼压急剧升高或因眼压升高引起的有症状视野丧失的病例。结论:平板玻璃体切除术后眼内气体完全充满的患者似乎可以安全地陆路穿越山峰,最高上升3895英尺,最终上升2787英尺,平均速率为29英尺/分钟。这些发现会严重影响患者的费用和便利性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号